B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL).
Leukemia
; 28(10): 2109-12, 2014 Oct.
Article
in En
| MEDLINE
| ID: mdl-24919804
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gene Expression Regulation, Neoplastic
/
Lymphoma, T-Cell, Cutaneous
/
Src-Family Kinases
Limits:
Animals
/
Humans
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2014
Document type:
Article
Affiliation country:
Denmark
Country of publication:
United kingdom